Are Shree Ganesh Bio latest results good or bad?
Shree Ganesh Biotech India reported strong sales growth of 120.51% year-on-year, reaching Rs 17.42 crore, but faced significant challenges with a profit after tax of Rs -0.95 crore and declining operating metrics, indicating mixed financial results.
Shree Ganesh Biotech India has reported its financial results for the quarter ending March 2025, revealing a mix of operational trends. The company's net sales for the latest six months reached Rs 17.42 crore, demonstrating a year-on-year growth of 120.51%, which is a notable achievement compared to the previous twelve-month period's sales of Rs 13.44 crore. This indicates a strong sales trend for the company.However, the financial results also highlight significant challenges. The profit after tax (PAT) for the quarter is reported at Rs -0.95 crore, reflecting a substantial decline year-on-year. Additionally, the operating profit (PBDIT) has fallen to Rs -1.41 crore, marking its lowest level in the last five quarters. The profit before tax (PBT) also reached a five-quarter low at Rs -1.42 crore. Furthermore, earnings per share (EPS) have decreased to Rs -0.02, indicating declining profitability and reduced earnings for shareholders.
It is also noted that the company experienced an adjustment in its evaluation over the past three months. Overall, while Shree Ganesh Biotech India has shown strong sales growth, the decline in profitability and operating metrics presents a complex picture of its financial health.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
